Skip to product information
1 of 1

Elabscience

SKU:PKSV030288

Recombinant MERS-CoV Nucleocapsid Protein

Recombinant MERS-CoV Nucleocapsid Protein

Regular price $255.00 USD
Regular price Sale price $255.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant MERS-CoV Nucleocapsid Protein, a cutting-edge product designed to facilitate advanced research and development in the field of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). This meticulously engineered protein offers a unique opportunity to delve deeper into the intricate mechanisms of MERS-CoV, enabling scientists and researchers to unravel its complexities.

Crafted with utmost precision, the Recombinant MERS-CoV Nucleocapsid Protein showcases exceptional purity and stability, ensuring reliable and reproducible results. Its recombinant nature allows for enhanced control and manipulation, granting researchers the ability to explore various aspects of MERS-CoV with unparalleled accuracy.

This remarkable protein serves as an invaluable tool for investigating the interactions between MERS-CoV and host cells, shedding light on the virus's pathogenesis and aiding in the development of effective therapeutic interventions. Its high affinity for nucleic acids facilitates the study of viral replication, transcription, and packaging, providing crucial insights into the viral life cycle.

The Recombinant MERS-CoV Nucleocapsid Protein is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures to ensure utmost purity and integrity. Its exceptional stability and solubility make it an ideal choice for a wide range of applications, including protein-protein interaction studies, drug screening assays, and vaccine development.

With its unrivaled quality and versatility, the Recombinant MERS-CoV Nucleocapsid Protein stands as an indispensable asset for researchers and scientists dedicated to unraveling the mysteries of MERS-CoV. Elevate your research endeavors to new heights with this groundbreaking product, poised to revolutionize the understanding and management of MERS-CoV.
View full details